SUBSCRIBE
SUBSCRIBE
News   FDA

Europe Approves Wyeth’s Enbrel for Psoriasis in Children

January 8, 2009 | 
1 min read
LONDON, Jan 8 (Reuters) - Wyeth's established drug Enbrel has been approved by the European Commission as the first biologic treatment for children with severe plaque psoriasis, the U.S. company said on Thursday.
FDA Approvals Europe
MORE ON THIS TOPIC
Female hand showing thumbs up gesture on blue background, art collage. Positive hand sign. Fashion collage in the style of Thumbs up magazine. Contemporary art. Modern design.
Rare diseases
UCB Wins First FDA Approval for Ultra-Rare Mitochondrial Disease
November 4, 2025
 · 
2 min read
 · 
Tristan Manalac
FDA CDER director George Tidmarsh speaking in an FDA video
FDA
UPDATE: Tidmarsh Waffles on Resignation, Will Fight To Clear Name
November 3, 2025
 · 
3 min read
 · 
Tristan Manalac
Pictured: uniQure headquarters in Amsterdam
Huntington’s disease
FDA Does ‘About-Face’ on UniQure’s Huntington’s Gene Therapy
November 3, 2025
 · 
3 min read
 · 
Heather McKenzie
Silver Spring, MD, USA - June 25, 2022: The FDA White Oak Campus, headquarters of the United States Food and Drug Administration, a federal agency of the Department of Health and Human Services (HHS).
Gene editing
FDA Eyes Accelerated Reviews for Gene Editing Therapies
November 3, 2025
 · 
2 min read
 · 
Tristan Manalac